None listed
Conditions
Brief summary
Our team has developed a device to reduce the risk that patients suffering from infectious airborne diseases such as COVID-19, influenza and tuberculosis can transmit these diseases in hospital settings to staff, visitors and other patients. The device is, deployed over the patient bed and can be attached to an air purifier. There is no hospital grade device registered by the TGA currently available that provides these specifications. This gap in medical device provision has necessitated this improvised solution. This study aims to deploy the laboratory tested equipment in a controlled hospital environment to test feasibility of use.
Interventions
The intervention is an aerosol containment device placed over the head of a patient's hospital bed either during transport between wards in a hospital environment or during care on the ward. It is approximately 1.5m high and 1.5m in length. Made of transparent plastic and does not seal completely around the patient but is open at the front. The intervention will be assembled and applied by hospital staff.
Importantly, the device is not designed to directly change the course of the patient's illn
The intervention is an aerosol containment device placed over the head of a patient's hospital bed either during transport between wards in a hospital environment or during care on the ward. It is approximately 1.5m high and 1.5m in length. Made of transparent plastic and does not seal completely around the patient but is open at the front. The intervention will be assembled and applied by hospital staff. Importantly, the device is not designed to directly change the course of the patient's illness but rather to prevent or reduce the risk that the patient spreads their illness to other patients, staff or visitors to the hospital. The device will either be applied for transfer between hospital locations (eg. emergency department and ward) or on the ward for a 24hr period. Adherence and fidelity will be recorded as part of a custom designed survey that will be administered at the time of device usage.
Sponsors
Monash Partners
Study design
Allocation
Non-randomised trial
Intervention model
Other
Primary purpose
Prevention
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Consecutive patients admitted to the emergency department or ward with suspected or confirmed COVID-19, influenza or tuberculosis.
Exclusion criteria
Inability to provide consent. Age less than 18 years. Inability to communicate in English as determined by the lead investigator at the time of consent.
Outcome results
None listed